Pengaruh Lamanya Pengobatan Terhadap Profil Darah pada Penderita Tuberkulosis Paru di Puskesmas Oesapa

Ni Made Susilawati; Novian Agni Yudhaswara; Karol Octrisdey

doi:10.59680/ventilator.v1i4.706

Authors

Ni Made Susilawati Poltekkes Kemenkes Kupang
Novian Agni Yudhaswara Poltekkes Kemenkes Kupang
Karol Octrisdey Poltekkes Kemenkes Kupang

DOI:

https://doi.org/10.59680/ventilator.v1i4.706

Keywords:

Pulmonary Tuberculosis, Blood Glucose, Uric Acid, Hemoglobin

Abstract

Control efforts with the DOTS (Directly Observed Treatment Short-course) strategy have been implemented. The side effects of this drug will continue as long as the sufferer takes it, furthermore anti-TB drugs (OAT) will change the metabolism in the sufferer's body. Chronic effects that arise from OAT treatment include increased levels of uric acid, glucose and hemoglobin in the blood. From the results of a preliminary study, data collection was carried out on the number of pulmonary TB sufferers in Kupang City in 2021, amounting to 385. Of this number, 72 cases were found at the Oesapa Community Health Center who were smear positive for pulmonary TB and had recovered and were still undergoing treatment. For this reason, it is necessary to carry out research to determine blood glucose, uric acid and hemoglobin levels in pulmonary tuberculosis (TB) patients who take OAT (anti-TB drugs) before taking, after taking 2 months and 6 months of treatment. This research method is descriptive and statistical. Statistical analysis using One Way Anova and Linear Regression tests was used to determine the effect of length of treatment on blood profiles in pulmonary tuberculosis sufferers. TB sufferers with anti-tuberculosis drug therapy at the Oesapa Community Health Center based on the age of the patient, there were 11 sufferers aged <30 years (55%), 9 sufferers aged >30 years (45%). Based on gender, 13 sufferers were female (65%), 7 sufferers were male (35%). Hemoglobin levels checked before treatment showed a mean of 13.015 g/dL, during 2 months of treatment 13.185 g/dL, and after 6 months of treatment the mean was 11.94 g/dL. The current blood sugar levels from table 1.3 above which were checked before treatment showed an average of 137.7 g/dL, during 2 months of treatment 145.15 g/dL, and after 6 months of treatment the average was 144.15 g/dL. Uric acid levels were based on the respondent's length of treatment with an average uric acid level before treatment of 6.16 mg/dL, 2 months of treatment 5.92 mg/dL and 6 months of treatment 6.43 mg/dL. Hemoglobin levels, instant blood sugar and uric acid before, 2 months and 6 months of treatment showed a p value <0.05, meaning the data was not normally distributed. The results of the analysis using the Friedman anova test showed a p value (0.137) > 0.05. This means there is no difference in uric acid measurement values ??before, 2 months and 6 months of treatment. The results of the analysis using the Friedman anova test showed a p value (0.142) > 0.05. This means that there is no difference in blood sugar measurement values ??before, 2 months and 6 months of treatment. The results of the analysis using the Friedman anova test showed a p value (0.378) > 0.05. This means there is no difference in Hb measurement values ??before, 2 months and 6 months of treatment

References

LITBANG BADAN KESEHATAN, LEMBAGA PENERBIT. LAPORAN RISKESDAS NTT TH 2018 [Internet]. LEMBAGA PENERBIT LITBANG BADAN KESEHATAN; 2018. Available from: http://ejournal2.litbang.kemkes.go.id/index.php/lpb/article/view/3654

Dinas Kesehatan Kota Kupang. Profil Dinkes Kota Kupang tahun 2017. 2017;(0380). Available from: https://dinkes-kotakupang.web.id/bank-data/categori/1-profil-kesehatan.html

Kemenkes RI. Tuberkulosis ( TB ). Tuberkulosis [Internet]. 2018;1(april):2018. Available from: www.kemenkes.go.id

Kementrian Kesehatan Republik Indonesia. Pengobatan Pasien Tuberkulosis. Kementeri Kesehat Republik Indones [Internet]. 2017;1–117. Available from: http://www.ljj-kesehatan.kemkes.go.id/pluginfile.php/4607/coursecat/description/Pengobatan Pasien TB.pdf

Fei CM, Zainal H, Hyder Ali IA. Evaluation of adverse reactions induced by anti-tuberculosis drugs in hospital Pulau Pinang. Malaysian J Med Sci. 2018;25(5):103–14.

Sadewo SW, Salam A, Rialita A. Gambaran Status Anemia pada Pasien Tuberkulosis Paru. J Cerebellum. 2016;2:590–600.

Ulfah U. Tuberkulosis GAMBARAN KADAR ASAM URAT PADA PENDERITA TUBERKULOSIS PARU YANG MENGKONSUMSI OBAT ANTI TUBERKULOSIS (OAT). J Kesehat Rajawali. 2022;11(2):40–5.

Susilawati NM, Octrisdey K, Fransiska. Prevalensi Penderita Tuberkulosis Paru Di Puskesmas Oekabiti Kecamatan Amarasi Kabupaten Kupang Periode 2017-2020. J Kesehat dan Kedokt. 2023;2(1):49–53.

Nurjana MA. Faktor Risiko Terjadinya Tubercolosis Paru Usia Produktif (15-49 Tahun) di Indonesia. Media Penelit dan Pengemb Kesehat. 2015;25(3):163–70.

Marissa N, , R, Wilya V, Febriansyah E, Ramadhan N, , A, et al. Tes Cepat Molekuler sebagai Alat Diagnosis Tuberkulosis yang Resisten Rifampisin di Provinsi Aceh. J Biotek Medisiana Indones. 2021;9(2):147–59.

Indonesia MKR. Pedoman Nasional Pelayanan Kesehatan Tata Laksana Tuberkulosis. Keputusan Menteri Kesehatan Republik Indonesia. 2019.

Atomsa D, Abebe G, Sewunet T. Immunological markers and hematological parameters among newly diagnosed tuberculosis patients at Jimma University Specialized Hospital. Ethiop J Health Sci. 2014;24(4):311–8.

Nidianti E, Nugraha G, Aulia IAN, Syadzila SK, Suciati SS, Utami ND. Pemeriksaan Kadar Hemoglobin dengan Metode POCT (Point of Care Testing) sebagai Deteksi Dini Penyakit Anemia Bagi Masyarakat Desa Sumbersono, Mojokerto. J Surya Masy. 2019;2(1):29.

Rumiris M. Gambaran Ureum Penderit Tuberkulosis Paru Konsumsi Obat Anti Tuberkulosis ( OAT ) Selama Enam Bulan Di RS . Advent Medan Masnur Rumiris Politeknik Kesehatan kemenkes Ri Medan. MEDAN; 2020.

Abebe G, , Zegeye Bonsa WK. Treatment Outcomes and Associated Factors in Tuberculosis Patients at Jimma University Medical Center: A 5?Year Retrospective Study Gemeda. Int J Mycobacteriology. 2017;6(3):239–45.

Musdalipah, Eny Nurhikmah, Karmilah MF. Efek Samping Obat Anti Tuberkulosis ( Oat ) Dan Penanganannya Pada Pasien Tuberkulosis ( Tb ) Di Puskesmas Perumnas Kota Kendari. J Imiah Manuntun [Internet]. 2018;4(1):67–73. Available from: http://jurnal.akfarsam.ac.id/index.php/jim_akfarsam/article/view/144

RINI EKA ARISANTI. GAMBARAN KADAR ASAM URAT PADA PENDERITA TUBERKULOSIS PARU YANG MENGKONSUMSI OBAT ANTI TUBERKULOSIS (OAT) DI PUSKESMAS MULYOREJO KECAMATAN SUNGGAL. POLITEKNIK KESEHATAN KEMENKES MEDAN. MEDAN; 2020.

Auliya P, Oenzil F, Dia Rofinda ZD. Gambaran Kadar Gula Darah pada Mahasiswa Fakultas Kedokteran Universitas Andalas yang Memiliki Berat Badan Berlebih dan Obesitas. J Kesehat Andalas. 2016;5(3):528–33.

Gelaw Y, Getaneh Z, Melku M. Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis. Environ Health Prev Med. 2021;26(1):1–15.

Permana A. Gambaran Kadar Hemoglobin(Hb) Dan Leukosit Pada Penderita Tb Paru Dengan Lamanya Terapi OAT (Obat Anti Tuberculosis) Di Rumah Sakit Islam Jakarta Cempaka. Anakes J Ilm Anal Kesehat. 2020;6(2):136–43.